Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rothhaar Studien is a specialized clinical research organization and study center based in Berlin, Germany, focusing primarily on dermatological and inflammatory indications. The center operates as a high-performance site for Phase 2 through Phase 4 clinical trials, partnering with global pharmaceutical companies and contract research organizations to evaluate new therapeutic options. Led by Dr. med. Jörg Rothhaar, the facility provides comprehensive trial management, including patient recruitment, clinical monitoring, and data collection under strict GCP standards. Their expertise spans a wide range of skin conditions, including psoriasis, atopic dermatitis, and rare inflammatory diseases. The company is recognized for its high recruitment rates and quality of clinical data in the European clinical trial landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rothhaar Studien.